Complexation with β-cyclodextrin enhances apoptosis-mediated cytotoxic effect of harman in chemoresistant BRAF-mutated melanoma cells.
Antineoplastic Agents
/ administration & dosage
Apoptosis
/ drug effects
Cell Line, Tumor
Cell Movement
/ drug effects
Cell Survival
/ drug effects
Drug Resistance, Neoplasm
/ drug effects
Harmine
/ administration & dosage
Humans
Melanoma
/ drug therapy
Molecular Dynamics Simulation
Mutation
Proto-Oncogene Proteins B-raf
/ genetics
Skin Neoplasms
/ drug therapy
beta-Cyclodextrins
/ administration & dosage
Alkaloid
Apoptosis
Cyclodextrin
Harman
Skin cancer
Journal
European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences
ISSN: 1879-0720
Titre abrégé: Eur J Pharm Sci
Pays: Netherlands
ID NLM: 9317982
Informations de publication
Date de publication:
01 Jul 2020
01 Jul 2020
Historique:
received:
11
02
2020
revised:
27
03
2020
accepted:
15
04
2020
pubmed:
26
4
2020
medline:
23
3
2021
entrez:
26
4
2020
Statut:
ppublish
Résumé
Harman, a natural β-carboline alkaloid, has recently gained considerable interest due to its anticancer properties. However, its physicochemical characteristics and poor oral bioavailability have been limiting factors for its pharmaceutical development. In this paper, we described the complexation of harman (HAR) with β-cyclodextrin (βCD) as a promising alternative to improve its solubility and consequently its cytotoxic effect in chemoresistant melanoma cells (A2058 cell line). Inclusion complexes (βCD-HAR) were prepared using a simple method and then characterized by FTIR, NMR and SEM techniques. Through in silico studies, the mechanism of complexation of HAR with βCD was elucidated in detail. Both HAR and βCD-HAR promoted cytotoxicity, apoptosis, cell cycle arrest and inhibition of cell migration in melanoma cells. Interestingly, complexation of HAR with βCD enhanced its pro-apoptotic effect by increasing of caspase-3 activity (p < 0.05), probably due to an improvement in HAR solubility. In addition, HAR and βCD-HAR sensitized A2058 cells to vemurafenib, dacarbazine and 5FU treatments, potentializing their cytotoxic activity. These findings suggest that complexation of HAR with natural polymers such as βCD can be useful to improve its bioavailability and antimelanoma activity.
Identifiants
pubmed: 32334103
pii: S0928-0987(20)30142-1
doi: 10.1016/j.ejps.2020.105353
pii:
doi:
Substances chimiques
Antineoplastic Agents
0
beta-Cyclodextrins
0
Harmine
4FHH5G48T7
harman
82D6J0535P
Proto-Oncogene Proteins B-raf
EC 2.7.11.1
betadex
JV039JZZ3A
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
105353Informations de copyright
Copyright © 2020 Elsevier B.V. All rights reserved.
Déclaration de conflit d'intérêts
Declaration of Competing Interest There are no conflict of interest to declare.